Sebastian Brunemeier
Sebastian Brunemeier is Co-founder and General Partner at Healthspan Capital, a venture capital firm that seeks to invest in early-stage longevity biotech companies. In addition, he is CEO of ImmuneAGE Pharma, focused on immune system rejuvenation. Sebastian was a Principal at Apollo Health Ventures, the first and largest aging-focused venture capital fund in the world, as well as Co-Founder and Chief Investment Officer at Cambrian Biopharma, a biotech VC holding company focused on the biology of aging. He is an experienced CEO with a demonstrated history of working in the biotechnology industry, specializing in entrepreneurship, venture capital, molecular biology, biotech and drug development. He is also one of the Founding Fellows of OnDeck Longevity Biotech Fellowship. Their mission is to increase the number of people working to build longevity biotechnology companies.
Sebastian Brunemeier Professional Experience / Academic History
Professional Experience
-
Co-Founder, General Partner
-
Advisor, Founding Fellow of Longevity Biotech
-
Advisor, Pharma Practice & McKinsey Global Institute
Academic History
-
Ph.D., Biochemistry
CURRENT APPOINTMENTS
Board Member, Revivo Therapeutics
Board Member, Equator Therapeutics
Venture Scout, Picus Capital
Advisor, VitaDAO
Advisor, Samsara Therapeutics
Advisor, Molecule GmbH
FORMER AFFILIATIONS
CIO & Co-Founder, Cambrian Biopharma
CEO & Co-Founder, Cyclone Therapeutics
Principal, Apollo Health Ventures
Associate, Deep Knowledge Ventures
AWARDS AND RECOGNITION
Fulbright Fellow, Gulbenkian Institute
Caltech Chen Institute Fellowship
Amsterdam Excellence Scholarship
EU Erasmus Plus Full Scholarship
Max Planck Institute Grant
NATO/European Commission Seminar Scholar
Mensa: Karen Cooper Memorial Scholarship
Henry R. Kravis Prize
Skaggs-Oxford Fellowship, Scripps Research Institute
SENS Foundation Scholar, Buck Institute for Research on Aging
MEDIA
He has appeared as a guest on Real Vision.